Long Island ‘miracle’ patient finally goes home after battling COVID-19 for 111 days in 4 different hospitals

Click here for updates on this story

    MANHASSET, NY (WCBS) — He spent more than three months in multiple hospitals battling COVID-19.

But on Monday, a Valley Stream man was discharged, CBS2’s Natalie Duddridge reported.

Finally, after 111 days in the hospital, 33-year-old Tito Velasquez found the strength to walk out of Northwell Stern Family Center of Rehabilitation, to cheers and tears. He spoke with the help of his nurse interpreter.

When asked if he ever thought he wasn’t going to make it, “He said, no. He never gave up,” the nurse said.

He spent more than three months in multiple hospitals battling COVID-19.

But on Monday, a Valley Stream man was discharged, CBS2’s Natalie Duddridge reported.

Finally, after 111 days in the hospital, 33-year-old Tito Velasquez found the strength to walk out of Northwell Stern Family Center of Rehabilitation, to cheers and tears. He spoke with the help of his nurse interpreter.

When asked if he ever thought he wasn’t going to make it, “He said, no. He never gave up,” the nurse said.

Velasquez suffered two strokes and a collapsed lung. He fought for weeks and was moved to four different hospitals to work with specialists.

One video shows him walking for the first time after being taken off the vent.

“Seeing him stand up and take his first couple of steps … it was a beautiful and emotional moment for myself, all the staff,” said Dr. Richard Stumacher, chief of pulmonary and critical care at Northern Westchester Hospital.

Velasquez’s wife said they will never forget the doctors and nurses who saved his life.

“Very happy, very happy,” Juana Masa said.

Now the focus is on the future. Velasquez said his first order of business when getting home is having a good meal.

And, most importantly, he’s looking forward to spending time with his family.

That meal his wife was set to cook Monday night is his favorite — ham on the barbecue.

Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.